Sana Biotechnology (SANA) Operating Expenses (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Operating Expenses data on file, last reported at $48.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 3.98% year-over-year to $48.6 million; the trailing twelve-month figure through Mar 2026 stood at $55.7 million (down 9.48% YoY), and the FY2025 full-year result was $9.3 million, down 37.72% from the prior year.
• Operating Expenses rose to $48.6 million in Q1 2026, from $2.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $116.3 million in Q2 2023 to a low of -$182.2 million in Q4 2023.
• A 5-year average of $10.0 million and a median of $4.1 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses sank 245.76% in 2022 and surged 1147.35% in 2025, its largest moves.
• Tracing SANA's Operating Expenses over 5 years: stood at -$162.2 million in 2022, then slipped by 12.33% to -$182.2 million in 2023, then soared by 101.43% to $2.6 million in 2024, then rose by 6.56% to $2.8 million in 2025, then soared by 1651.22% to $48.6 million in 2026.
• Business Quant data shows SANA's Operating Expenses at $48.6 million in Q1 2026, $2.8 million in Q4 2025, and $2.0 million in Q3 2025.